Medical Weight Loss vs. Bariatric Surgery

At a glance

What it is — medical: Prescription medicine plus a lifestyle program; surgery: An operation on the stomach and/or small intestine Who it's for (adults) — medical: BMI ≥30, or ≥27 with a weight-related condition (NIDDK; FDA label for Zepbound); surgery: Recommended at BMI ≥35, or ≥30 with type 2 diabetes; considered at 30–34.9 if other methods fail (ASMBS) Typical results — medical: 3% to 12% more loss at 1 year than lifestyle alone, on average; more with some medicines (NIDDK); surgery: About 15% to 30% of starting weight, on average (NIDDK) Reversible? — medical: Yes, you can stop; some weight usually returns; surgery: Sleeve can't be reversed; bypass is difficult to reverse; band can be removed Main risks — medical: Vary by drug; Zepbound and Saxenda carry a thyroid cancer caution; surgery: Bleeding, infection, leaks, blood clots, nutrient deficiencies; follow-up procedures in about one-third within 5 years Commitment — medical: Ongoing medicine and check-ins; surgery: Lifelong vitamins, follow-up and habit changes

What is medical weight loss?

Medical weight loss means a doctor-supervised plan that adds prescription medicine to healthy eating and physical activity. NIDDK says medicines don't replace those habits; they work better combined with a lifestyle program.

**FDA-approved medicines for long-term use** (per NIDDK): orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), liraglutide (Saxenda), semaglutide (Wegovy) and tirzepatide (Zepbound). Liraglutide and semaglutide mimic the hormone GLP-1; tirzepatide mimics two hormones, GIP and GLP-1. Setmelanotide (Imcivree) is approved only for certain rare genetic causes of obesity.

**What results look like.** On average, adults taking a weight-loss medicine with a lifestyle program lose 3% to 12% more of their starting weight after a year than people in the program without medicine, and some lose 10% or more (NIDDK). In FDA's review of Zepbound, adults without diabetes on the highest approved dose lost on average 18% of body weight compared with placebo over 72 weeks.

**What to know.** - If you haven't lost at least 5% of your starting weight after 12 weeks on the full dose, your doctor will probably advise stopping (NIDDK). - You'll probably regain some weight after stopping (NIDDK). - FDA's approval announcement says Zepbound causes thyroid C-cell tumors in rats (it's unknown whether it does in humans) and shouldn't be used by people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2. NIDDK lists the same caution for liraglutide (Saxenda). - Some, but not all, insurance plans cover these medicines.

What is bariatric surgery?

Weight-loss surgery, also called metabolic and bariatric surgery, makes the stomach smaller, changes the small intestine, or both. It can also change gut hormones in ways that may reduce appetite and hunger (NIDDK). The main types:

- **Gastric sleeve** (sleeve gastrectomy): removes about 80% of the stomach, leaving a banana-shaped pouch. It can't be reversed. - **Gastric bypass** (Roux-en-Y): creates a small stomach pouch connected farther down the small intestine. Difficult to reverse. - **Adjustable gastric band:** an inflatable band around the upper part of the stomach. Less common today because of complications, mostly band removal. - **Biliopancreatic diversion with duodenal switch:** less commonly done; combines a sleeve with a larger intestinal bypass.

**What results look like.** NIDDK says many people lose an average of 15 to 30 percent of their starting weight, depending on the operation, and that some people regain part of it over time. Surgery can improve many obesity-related conditions, especially type 2 diabetes.

**Risks and follow-up.** Side effects can include bleeding, infection, leaks where the stomach or intestine is joined, diarrhea and blood clots. Follow-up procedures and hospital stays affect about one-third of patients within 5 years. Later problems can include poor nutrient absorption (leading to anemia or osteoporosis if you don't take prescribed vitamins) and gallstones. Rarely, complications can be fatal (NIDDK).

Who qualifies for each?

**Medicine.** Adults with a BMI of 30 or more, or 27 or more with a weight-related problem such as high blood pressure or type 2 diabetes (NIDDK). That matches FDA's approved use for Zepbound.

**Surgery.** Under the 2022 ASMBS/IFSO criteria: - Recommended at a BMI of 35 or more, regardless of other conditions - Recommended with type 2 diabetes and a BMI of 30 or more - Should be considered at a BMI of 30 to 34.9 if nonsurgical methods haven't produced substantial or durable weight loss

NIDDK says surgery is generally for adults who haven't been able to lose weight, or keep it off, with eating plans, exercise or medicine. Insurers, Medicare and Medicaid set their own criteria.

How to choose

Questions doctors typically weigh with you:

- **Your BMI and health conditions,** especially type 2 diabetes, high blood pressure and sleep apnea - **What you've already tried,** including medicines, and how you responded - **How much weight loss you need** to improve your health - **Your tolerance for surgery** and for lifelong vitamins and follow-up - **Other medical history,** such as thyroid cancer history or pregnancy plans, that rules out some medicines

Questions to ask your doctor

- Am I a candidate for medicine, surgery or both? - Which medicine would you suggest, and what if it doesn't work for me? - How much weight could I realistically lose with each option? - What happens if I stop the medicine? - Which operation fits me, and what follow-up does it require for life? - Who would perform the surgery, and how many of these operations do they do?

Sources and disclaimer

Sources: - National Institute of Diabetes and Digestive and Kidney Diseases (NIH), "Definition & Facts of Weight-loss Surgery" (niddk.nih.gov), fetched Oct. 30, 2026 - NIDDK, "Types of Weight-loss Surgery" (niddk.nih.gov), fetched Oct. 30, 2026 - NIDDK, "Weight-loss Surgery Side Effects" (niddk.nih.gov), fetched Oct. 30, 2026 - NIDDK, "Prescription Medications to Treat Overweight & Obesity" (niddk.nih.gov), fetched Oct. 30, 2026 - American Society for Metabolic and Bariatric Surgery, "Is Metabolic and Bariatric Surgery Right for You?" (asmbs.org), fetched Oct. 30, 2026 - U.S. Food and Drug Administration, "FDA Approves New Medication for Chronic Weight Management" (Nov. 8, 2023), fda.gov, fetched Oct. 30, 2026

This guide is general information, not medical advice. Talk to your doctor before starting, stopping or changing any treatment.